Erin Tallman - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Erin Tallman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Erin Tallman

Erin Tallman

Verified

Editor-in-Chief, Archiexpo E-Magazine

Marseille

Final Covers

psychology; nightmares; psychiatric disorders; visual perception; emotion regulation; self-perception; body image disturbance; face perception; internet memes; eye tracking insomniasleep medicine

Doesn’t Cover

Sex

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 703

  • ABIVAX's New Therapy for Ulcerative Colitis Gains Attention

    By Erin Tallman Verified| MedicalExpo E-Magazine Verified ABIVAX’s novel oral therapy, obefazimod, shows promising results in treating refractory ulcerative colitis by targeting upstream inflammatory pathways. In a webcast hosted on March 17, 2025, ABIVAX showcased their latest developments in ulcerative colitis (UC) treatment, presented by Dr. David T. Rubin, MD, a prominent gastroenterologist from the University of Chicago.

    By Erin Tallman Verified · MedicalExpo E-Magazine

    Apr. 14, 2025

  • Whole-body Imaging Critical for Elderly Trauma

    By Erin Tallman Verified| MedicalExpo E-Magazine Verified Rapid and comprehensive CT imaging is essential for detecting hidden trauma and life-threatening complications in elderly patients after even minor falls, ensuring timely diagnosis and intervention. Even a seemingly minor fall can result in life-threatening complications for elderly individuals, a population particularly vulnerable to hidden trauma. Falls are the leading cause of serious injury in adults over the age of 65, and the risks are even greater for those over 80.

    By Erin Tallman Verified · MedicalExpo E-Magazine

    Apr. 07, 2025

  • ABIVAX's New Therapy for Ulcerative Colitis Gains Attention

    By Erin Tallman Verified| MedicalExpo E-Magazine Verified ABIVAX’s novel oral therapy, obefazimod, shows promising results in treating refractory ulcerative colitis by targeting upstream inflammatory pathways. In a webcast hosted on March 17, 2025, ABIVAX showcased their latest developments in ulcerative colitis (UC) treatment, presented by Dr. David T. Rubin, MD, a prominent gastroenterologist from the University of Chicago.

    By Erin Tallman Verified · MedicalExpo E-Magazine

    Apr. 14, 2025

As seen in

Company Info

Archiexpo E-Magazine